Inventor
DELONG MITCHELL A
US68 patents
⚠️ This page may combine multiple inventors who share the name “DELONG MITCHELL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AERIE PHARMACEUTICALS INC
40 patentsUS9415043B2Aug 16, 2016
Combination therapy
AERIE PHARMACEUTICALS INC32 citations98
US9096569B2Aug 4, 2015
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC40 citations98
US8921392B2Dec 30, 2014
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC38 citations98
US8716310B2May 6, 2014
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC49 citations98
US8357699B2Jan 22, 2013
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC42 citations98
US8034943B2Oct 11, 2011
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC49 citations98
US7671205B2Mar 2, 2010
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC61 citations98
US10174017B2Jan 8, 2019
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC41 citations97
US10899714B2Jan 26, 2021
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC10 citations94
US10882840B2Jan 5, 2021
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC10 citations94
US10654844B2May 19, 2020
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC11 citations94
US10112920B2Oct 30, 2018
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC20 citations94
US9884840B2Feb 6, 2018
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC25 citations94
US10532993B2Jan 14, 2020
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC9 citations93
US9951059B2Apr 24, 2018
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC10 citations93
US10588901B2Mar 17, 2020
Combination therapy
AERIE PHARMACEUTICALS INC9 citations92
US10316029B2Jun 11, 2019
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC10 citations92
US9993470B2Jun 12, 2018
Combination therapy
AERIE PHARMACEUTICALS INC13 citations92
US9931336B2Apr 3, 2018
Combination therapy
AERIE PHARMACEUTICALS INC11 citations92
US9643927B1May 9, 2017
Process for the preparation of kinase inhibitors and intermediates thereof
AERIE PHARMACEUTICALS INC33 citations92
US9365518B2Jun 14, 2016
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC10 citations92
US7470787B2Dec 30, 2008
Isoquinoline compounds
AERIE PHARMACEUTICALS INC55 citations92
US11389441B2Jul 19, 2022
Ophthalmic compositions
AERIE PHARMACEUTICALS INC6 citations85
US11312700B2Apr 26, 2022
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AERIE PHARMACEUTICALS INC6 citations84
US11197853B2Dec 14, 2021
Combination therapy
AERIE PHARMACEUTICALS INC5 citations84
US11185538B2Nov 30, 2021
Compositions for treating glaucoma or reducing intraocular pressure
AERIE PHARMACEUTICALS INC5 citations84
US11028081B2Jun 8, 2021
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC6 citations84
US11020385B2Jun 1, 2021
Combination therapy
AERIE PHARMACEUTICALS INC7 citations84
US11021456B2Jun 1, 2021
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC5 citations84
US10568878B2Feb 25, 2020
Combination therapy
AERIE PHARMACEUTICALS INC6 citations84
US10472327B2Nov 12, 2019
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC6 citations84
US9963432B2May 8, 2018
Beta-amino-isoquinolinyl amide compounds
AERIE PHARMACEUTICALS INC10 citations84
US9890123B2Feb 13, 2018
6-aminoisoquinoline compounds
AERIE PHARMACEUTICALS INC5 citations84
US9849122B2Dec 26, 2017
Combination therapy
AERIE PHARMACEUTICALS INC7 citations84
US9512101B2Dec 6, 2016
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
AERIE PHARMACEUTICALS INC6 citations84
US10858339B2Dec 8, 2020
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AERIE PHARMACEUTICALS INC9 citations83
US11618748B2Apr 4, 2023
Dual mechanism inhibitors for the treatment of disease
AERIE PHARMACEUTICALS INC1 citations73
US11590123B2Feb 28, 2023
Ophthalmic compositions
AERIE PHARMACEUTICALS INC1 citations72
US11427563B2Aug 30, 2022
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AERIE PHARMACEUTICALS INC2 citations72
US11707460B2Jul 25, 2023
Ophthalmic compositions
AERIE PHARMACEUTICALS INC0 citations62
DELONG MITCHELL A
9 patentsUS8759388B2Jun 24, 2014
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
DELONG MITCHELL A39 citations98
US8450344B2May 28, 2013
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
DELONG MITCHELL A51 citations98
US8394826B2Mar 12, 2013
Dual mechanism inhibitors for the treatment of disease
DELONG MITCHELL A57 citations98
US8455514B2Jun 4, 2013
6-and 7-amino isoquinoline compounds and methods for making and using the same
DELONG MITCHELL A43 citations97
US8455647B2Jun 4, 2013
6-aminoisoquinoline compounds
DELONG MITCHELL A44 citations97
US8455513B2Jun 4, 2013
6-aminoisoquinoline compounds
DELONG MITCHELL A44 citations97
US8871757B2Oct 28, 2014
6-and 7-amino isoquinoline compounds and methods for making and using the same
DELONG MITCHELL A36 citations94
US8722739B2May 13, 2014
Amino acid salts of prostaglandins
DELONG MITCHELL A5 citations73
US8623918B2Jan 7, 2014
Amino acid salts of prostaglandins
DELONG MITCHELL A4 citations73
UNIV DUKE
1 patentShowing the top 50 of 68 patents by PatentIndex Score.